Portfolio Management - Wednesday, November 9, 2011

Arrive Early To Attend Ninth Annual Strategic Resource Management

12:00 PM LUNCHEON PRESENTATION

Sponsored by
Tales from the Portfolio Trenches:
Case Studies in Effective Portfolio Management

David Smith, Vice President, Enrich Consulting

Enrich Consulting deploys R&D portfolio management systems for medium and large R&D-driven organizations. In this talk, we will provide a few case studies that highlight best practices in project valuation and portfolio management:

• Appropriate scenario analysis at the project and portfolio levels
• Managing a distributed process: Methods that help and methods that overwhelm
• Pipeline and attrition modeling: Finding the right level of detail

Interactive Breakout Discussion Groups: B

3:45 Breakout Discussion Groups and Afternoon Wrap Up:

Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss some of the key issues presented earlier in the day’s sessions. Delegates will join a table of interest to them and become an active part of the discussion at hand. To get the most out of this interactive session and format please come prepared to share examples from your work, vet some ideas with your peers, be a part of group interrogation and problem solving, and, most importantly, participate in active idea sharing.

TABLE:  Driving Innovation and Value through Portfolio Management

Moderator:  Beau Bush, Strategy & Portfolio Analysis, Global Strategic Marketing and Market Access (GSM&MA), Johnson & Johnson Pharmaceutical Services LLC

• How are trade-offs made between traditional pharmaceutical projects and enabling technologies in your portfolio
• How to value a biomarker or diagnostics platforms in your portfolio
• Making sure your forecasts and development plans talk to each other

TABLE:  Leading Executives to Effective Portfolio Decision-Making

Moderator:  Christopher Gajda, Director, Program Management & Strategic Operations, Amgen

• Framing portfolio decisions
• Determining the right level of data
• Capturing and communicating the rationale to ensure successful execution

TABLE: Quantifying Risk in R&D projects

Moderator:  Jeffrey Handen, Ph.D., Vice President, Clinical Solutions, Medidata Solutions Worldwide

•  How do you measure risk?
•  Technical vs. Operational Risk
•  De-risking: Project vs. Portfolio

TABLE:  Alignment of Project Management and Resource Management

Moderator:  Cleat Jerden, Senior Project Manager, Process Development, Amgen, Inc.

• How resource management is included in project planning
• Resource tracking throughout project execution
• Selection process for project resources

TABLE:  Balancing Project Manager Workload

Moderator:  Mary Maley, Global Program Director, RQT (Research, Quality, Technology), Kellogg Company

• How do you forecast the amount of time a project will take?
• How do you assess the capacity of your project managers?
• How do you prioritize across customers and transition projects to maintain balance?

TABLE:  Managing Technology/Development Initiatives in a Matrix Environment

Moderator:  Jennifer Nemeth, Ph.D., Principal Research Scientist, Biologics Research, Centocor R&D, A Division of J&J PRD

• The hurdles of managing daily business requirements and still make deliverables on your Initiative.
• The difficulties of wearing many “Hats” in a matrix environment.
• Getting management support for your Technology/Development Initiative.

TABLE:  Should Pharma Abandon the Fully Integrated Model and Focus its Efforts on a Subset of the Value Chain?

Moderator:  James Resch, Ph.D., Director, Strategic Intelligence, Discovery Strategy and Performance, AstraZeneca Pharmaceuticals, Inc.

• Which internal skill sets offer the best chance of delivering value and competitive advantage?
• Which portions of the value chain would be the easiest to partner or outsource?
• What are the benefits and risks to a more focused strategy?

TABLE:  Achieving Excellence in Portfolio Management:  A Best Practice Approach

Moderator:  Michael Menke, Ph.D., Adjunct Professor, Engineering and Technology Management, Portland State University; President at Value Creation Associates; former Chief Portfolio Advocate, Hewlett-Packard

Most business processes are built upon a foundation of business practices and the quality of the process output depends heavily on implementing the right practices, doing them whenever necessary and executing them well.  This breakout session will explore:
• What are the most important practices for excellence portfolio management?
     o Which ones are essential for excellence?
     o Which ones can confer competitive advantage?
• Are there standards (benchmarks) to measure ourselves against?
• How does pharma compare to other industries?
These results are from an international portfolio management benchmarking study conducted in May 2011.

Please share your topic requests and suggestions with us:  mlieberman@healthtech.com